Poslední zkoušky

EudraCT Number: 2004-004051-19

Sponsor Protocol Number: IM101-042

Start Date: 2005-05-13

Sponsor Name: Bristol-Myers Squibb International Corporation

Full Title: A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy with Glucocorticosteroids vs. Placebo plus Gluc...

Medical condition: SYSTEMIC LUPUS ERYTHEMATOSUS, NOS

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) SE (Prematurely Ended) BE (Completed) AT (Completed) IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-004960-64

Sponsor Protocol Number: F1J-MC-HMDW(b)

Start Date: 2005-05-13

Sponsor Name: Eli Lilly and Company Limited

Full Title: A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder

Medical condition: Generalised Anxiety Disorder

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2005-001171-36

Sponsor Protocol Number: TG-MV-001

Start Date: 2005-05-13

Sponsor Name: ThromboGenics Ltd.

Full Title: A Dose-Escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy

Medical condition: Vitreomacular Traction Maculopathy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-004509-11

Sponsor Protocol Number: dopa_HSP

Start Date: 2005-05-13

Sponsor Name: University hospital of the University of Ulm

Full Title: Efficiency and tolerability of L-Dopa in patients with Hereditary Spastic Paraplegia (HSP)

Medical condition: Hereditary spastic paraplegias (HSP) are a rare neurodegenerative group of disorders characterised by slowly progressive symmetric spastic paraparesis, distal pallhypaesthesia of the lower limbs, a...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-002620-18

Sponsor Protocol Number: IM101-046

Start Date: 2005-05-13

Sponsor Name: Bristol-Myers Squibb International Corporation

Full Title: A Multi-National Randomized, Double-Blind, Exploratory Study of Abatacept versus Placebo in Preventing the Development of Rheumatoid Arthritis in Adult Subjects with Undifferentiated Inflammatory A...

Medical condition: Rheumatoid Arthritis, NOS

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed) BE (Completed) IT (Completed) ES (Completed)

Trial results: (No results available)

EudraCT Number: 2005-000361-19

Sponsor Protocol Number: CSPP100A2242

Start Date: 2005-05-13

Sponsor Name: Novartis Pharma Services AG

Full Title: An open-label, one-period, one-treatment study which objective is to evaluate the time course of the antiproteinuric and blood pressure lowering effect of renin inhibition with Aliskiren in patient...

Medical condition: Hypertension

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: View results

EudraCT Number: 2004-004901-12

Sponsor Protocol Number: SFOLFOX/SFOLFIRI vs FOLFOX/FOLFIRI

Start Date: 2005-05-13

Sponsor Name: TEVA Pharma Belgium

Full Title: Phase II randomized study of Combined Infusional Leucovorin Sodium and 5-FU Versus the Classical Sequential administration of Leucovorin Calcium followed by 5-FU both in combination with standard ...

Medical condition: Histologically confirmed adenocarcinoma of the colon or the rectum and unresectable metastases or advanced locoregional disease

Disease:	Version	SOC Term	Classification Code	Term	Level
			10052360

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: (No results available)

EudraCT Number: 2005-000706-31

Sponsor Protocol Number: IMMU-103-04

Start Date: 2005-05-13

Sponsor Name: Immunomedics, Inc.

Full Title: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Studyof Epratuzumab in Patients with Active Systemic Lupus Erythematosus

Medical condition: Systemic Lupus Erythematosus

Disease:	Version	SOC Term	Classification Code	Term	Level
			10042945

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) DE (Prohibited by CA) BE (Completed) IT (Prematurely Ended) ES (Completed)

Trial results: View results

EudraCT Number: 2004-002106-29

Sponsor Protocol Number: ET-743-STS-201

Start Date: 2005-05-13

Sponsor Name: Pharma Mar SA Unipersonal

Full Title: A Randomized, Multicenter, Open-label Study of YONDELIS ™ (ET-743 ecteinascidin) Administered by 2 Different Schedules (Weekly for 3 of 4 weeks vs. q3 Weeks) in Subjects With Locally Advanced or Me...

Medical condition: Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	5.0		10039494		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) IT (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-004586-14

Sponsor Protocol Number: BILA 1704/RAE

Start Date: 2005-05-13

Sponsor Name: FAES FARMA S.A.

Full Title: Double-blind, randomised, placebo-controlled, phase III study comparing the efficacy and safety of bilastine 20 mg once daily and cetirizine 10 mg for the treatment of allergic allergic rhinitis

Medical condition: Seasonal Allergic Rhinitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) BE (Completed) DE (Completed) ES (Ongoing)

Trial results: (No results available)

Poslední zkoušky

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence